/Investor DB

William Blair — 2026 Investments

3 investments dated 2026 · listed companies and verified rows first · show all

Neurogeneneurogene.comin𝕏NASDAQ: NGNEJun 2026

Neurogene develops gene therapy treatments for rare neurological diseases.

BiotechDeep TechDigital HealthLongevityMedical DevicesNew York, US

Rachel McMinn(Founder and Chief Executive Officer)inRachel McMinn, Ph.D.(Founder and Chief Executive Officer)

BoardCory Freedland(Director)inStephen Biggar(Director)

Co-investorsEcoR1 CapitalSamsara BioCapitalCasdin CapitalREDMILERTW Investments L.P.

Cantoncanton.networkin𝕏Jun 2026

Canton is a privacy-enabled public blockchain (Layer 1) that connects previously siloed financial systems, letting regulated institutions exchange tokenized assets and data with privacy controls and real-time synchronization.

Crypto & Web3Data & InfrastructureFintech

Yuval Rooz(Founder)

Co-investors1/1 Capital10SQ Capital (TenSquared)1521 VenturesLongHash Venturesa16z cryptoAlumni Ventures+20 more

Digital Asset Holdingsdigitalasset.comin𝕏Jun 2026

Digital Asset (DA) is the creator of the Canton Network, a privacy-enabled blockchain for global financial markets that supports tokenization of real-world assets and connects traditional and decentralized finance.

Crypto & Web3Enterprise SoftwareFintechNew York, US

Yuval Rooz(Co-Founder & CEO)inEric Saraniecki(Co-Founder & Head of Network Strategy)Shaul Kfir(Co-Founder)inJuan Lorenzana(Executive Officer)inEdward Lawrence Janulis(Executive Officer)

Co-investorsAlumni VenturesR136 VenturesSmash Capitala16z cryptoBNP ParibasBroadridge+25 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.